You have 9 free searches left this month | to do more

abl001

Abl001 is a drug used to treat Chronic Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Hepatic Impairment, and other conditions. Abl001 is being actively studied in 5 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative SiteMarlise R. Luskin
Handok Inc.Alaska Oncology and Hematology AOH (2)
Marlise R. LuskinAsan Medical Center
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Recruiting
  • P1b: Advanced Solid Tumors
  • P2: Biliary Tract Cancer
  • ABL001
  • +2 more
  • Seongnam-si, Korea, Republic of
  • +3 more
2021-08-06
Aug 6, 2021
N
Completed
  • Hepatic Impairment
  • ABL001
  • Miami, Florida
  • +2 more
2020-12-06
Dec 6, 2020
N
Recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • ABL001
  • +3 more
  • Boston, Massachusetts
  • +18 more
2021-11-27
Nov 27, 2021
M
Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • ABL001
  • +2 more
  • Chicago, Illinois
  • +4 more
2021-11-30
Nov 30, 2021
N
Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +86 more
2021-11-16
Nov 16, 2021
N
Recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • ABL001
  • Anchorage, Alaska
  • +17 more
2021-11-28
Nov 28, 2021